Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial

Author: Schellhammer P.F.   Sharifi R.   Block N.L.   Soloway M.S.   Venner P.M.   Patterson A.L.   Sarosdy M.F.   Vogelzang N.J.   Schellenger J.J.   Kolvenbag G.J.C.M.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.50, Iss.3, 1997-09, pp. : 330-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content